Competing Statement Declarations
DB and SA have received compensation for consultancies, presentations
and advisory board activities but no companies were involved in the
decision to write and submit this manuscript. LFB has nothing to
disclose. SA has received consultancy from Novartis and Roche. DB has
received compensation for activities related to Canbex therapeutics,
InMune Biol, Lundbeck, Japan tobacco, Merck, Novartis.